Updated 02:01 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,868.50 -0.46% CL 85.14 -3.86% BTC 65,305.22 0.00%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,869 −0.46% BTC $65,305 VIX 22.91 +18.70% latest tape · as of 02:01 UTC
The Screen · Financials · Banks - Regional

Origin Bancorp, Inc. logoOrigin Bancorp, Inc.

OBK · the NYSE · USD · Market cap $1.6B · 1,000 employees

Origin Bancorp, Inc.

FAIL · Does not pass the screen
54.06 USD

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price54.06 USD at the 13 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.06)
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $52.56 to $87.59, base estimate $62.00 (screen dated 2026-11-13).

Current read
Markup ?
Undervalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.06, read 2026-11-15
  • Ethical does not pass the values gate
Price54.06 USD
Fair value62.00
Ethical score30.0/100
Value readUndervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-11-11Read Markup54.24-0.3% to today Markdown gives way to Markup first Markup read since August
2026-09-08Read Markdown54.48-0.8% to today ✓Markup gives way to Markdown with results news in the headlines
2026-08-07Read Markup54.98-1.7% to today Accumulation gives way to Markup after a 10% rise in 5 weeks
2026-07-02Read Accumulation50.14+7.8% to today ✓First review on file: Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Origin Bancorp, Inc. holds its Markup at $54.06. Consolidating, no directional conviction, held for 1 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 1 days
Price at the screen$54.06
Valuation12.99 trailing · 11.51 forward price to earnings
Values screenFAIL · score 30.0
Beta0.73
The Workings

Five Screens, Shown in Full

Does not pass. Prohibited keyword in sector/industry: bank

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Prohibited keyword in sector/industry: bank Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Origin Bancorp, does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when OBK's ethical verdict changes

Today OBK does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 13% discount to our $62.00 fair value, 51.50% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

52.56Conservative62.00Base case87.59Growth case 54.06Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 12.8% discount to the base estimate.

The Street's Range
57.00Street low 62.00Street average 62.00Street high 54.06Price

Third-party analyst targets: 5 covering, consensus Buy. The average target sits +15% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $62.00, with a range of $52.56 to $87.59, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Banks Always Fail Our Ethical Screen

Every time a small business in Texas needs a loan or a municipality in Mississippi parks its cash, the money moves through a regional bank like Origin. We pass on this one outright because it fails our ethical screen on the prohibited bank sector, regardless of the numbers. This is exactly what the screen exists for.

The business shows 9% revenue growth and a 23% profit margin but only a 7% ROE at a forward multiple of 12.3 times, with analysts clustered around a modest buy rating and $55 target against the current price. Those figures do not overcome the ethical block.

Risk sits in heavy regulatory exposure and thin capital returns that leave little room for error in a rising-rate environment. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E11.5xcheap for a company growing this fast
Trailing P/E13.0xreasonably valued
EPS, trailing4.14
EPS, forward4.67
Revenue growth+51.5%growing very fast
Profit margin31.1%highly profitable on every dollar of sales
Return on equity10.4%a modest return on shareholder capital
Dividend yield2.11%
Beta0.73steadier than the market
Short interest, float0.03%
52-week range32.28 - 58.00
Market cap$1.6B
Employees1,000

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

OBK trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-11 Markup · changed $54.24 +1.2% Entry 17

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52.

2026-11-04 Markdown $53.62 +3.6% Entry 16

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 3.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52.

2026-10-28 Markdown $51.77 +1.1% Entry 15

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Markdown $51.21 +0.0% Entry 14

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Markdown $51.21 +0.0% Entry 13

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Markdown $51.21 +0.0% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Markdown $51.21 +0.0% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Markdown $51.21 +0.0% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-22 Markdown $51.21 +0.0% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-21 Markdown $51.21 +0.0% Entry 8

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $52. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on OBK

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in OBK's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $45.95 +6.9% $0.25 $1,074 +7.4%
2 months $44.56 +10.2% $0.25 $1,108 +10.8%
3 months $40.59 +21.0% $0.25 $1,216 +21.6%
6 months $38.60 +27.2% $0.40 $1,283 +28.3%
1 year $34.73 +41.4% $0.70 $1,434 +43.4%
2 years $28.31 +73.4% $1.30 $1,780 +78.0%
3 years $29.20 +68.2% $1.90 $1,747 +74.7%
5 years $40.83 +20.3% $3.04 $1,277 +27.7%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever OBK does next, these words stay.

Origin Bancorp, Inc. · OBK · Markup · $54.06
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.